Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Database
Language
Publication year range
1.
AAPS PharmSciTech ; 23(7): 281, 2022 Oct 14.
Article in English | MEDLINE | ID: mdl-36241775

ABSTRACT

Pulmonary delivery systems should administer a high dose of the required formulation with the designated dry powder inhaler (DPI) to achieve therapeutic success. While the effects of device geometry and individual components used on powder dispersion are described in literature, potential effects of DPI surface properties on powder retention within the device and deagglomeration have not been adequately studied, but could impact inhalation therapy by modifying the available dose. For this, inner parts of a model DPI were modified by plasma treatment using various processes. Since both the hydrophilic-hydrophobic and structural properties of the surface were altered, conclusions can be drawn for future optimization of devices. The results show that surface topography has a greater influence on powder deposition and deagglomeration than hydrophilic or hydrophobic surface modification. The most important modification was observed with an increased rough surface texture in the mouth piece, resulting in lower powder deposition in this part (from 5 to 1% quantified amount of powder), without any change in powder deagglomeration compared to an untreated device. In summary, increasing the surface roughness of DPI components in the size range of a few nanometers could be an approach for future optimization of DPIs to increase the delivered dose.


Subject(s)
Dry Powder Inhalers , Administration, Inhalation , Aerosols/chemistry , Dry Powder Inhalers/methods , Equipment Design , Particle Size , Pharmaceutical Preparations , Powders/chemistry
2.
Pharmaceutics ; 14(6)2022 May 31.
Article in English | MEDLINE | ID: mdl-35745758

ABSTRACT

Commercially available dry powder inhalers (DPIs) are usually devices in a fixed combination with the intended formulation, and a change in medication by the physician often forces the patient to use a different device, requiring the patient to relearn how to use it, resulting in lower adherence and inadequate therapy. To investigate whether DPIs can achieve successful outcomes regardless of the formulation and flow rate used, a novel DPI and two commercially available devices were compared in vitro for their deagglomeration behavior for different binary blends and a spray-dried particle formulation. The results demonstrate that the novel device achieved the highest fine particle fraction (FPF) regardless of the formulations tested. In the binary mixtures tested, the highest emitted fraction was obtained by shaking out the powder due to the oscillating motion of the capsule in the novel device during actuation. For DPIs with high intrinsic resistance to airflow, similar FPFs were obtained with the respective DPI and formulation, regardless of the applied flow rate. Additionally, the development and use of binary blends of spray-dried APIs and carrier particles may result in high FPF and overcome disadvantages of spray-dried particles, such as high powder retention in the capsule.

3.
J Neurosci ; 30(41): 13838-49, 2010 Oct 13.
Article in English | MEDLINE | ID: mdl-20943924

ABSTRACT

During formation of the optic projection in astray/robo2 mutant zebrafish, optic axons exhibit rostrocaudal pathfinding errors, ectopic midline crossing and increased terminal arbor size. Here we show that these errors persist into adulthood, even when robo2 function is conditionally reduced only during initial formation of the optic projection. Adult errors include massive ectopic optic tracts in the telencephalon. During optic nerve regeneration in astray/robo2 animals, these tracts are not repopulated and ectopic midline crossing is reduced compared with unlesioned mutants. This is despite a comparable macrophage/microglial response and upregulation of contactin1a in oligodendrocytes of entopic and ectopic tracts. However, other errors, such as expanded termination areas and ectopic growth into the tectum, were frequently recommitted by regenerating optic axons. Retinal ganglion cells with regenerating axons reexpress robo2 and expression of slit ligands is maintained in some areas of the adult optic pathway. However, slit expression is reduced rostral and caudal to the chiasm, compared with development and ubiquitous overexpression of Slit2 did not elicit major pathfinding phenotypes. This shows that (1) there is not an efficient correction mechanism for large-scale pathfinding errors of optic axons during development; (2) degenerating tracts do not provide a strong guidance cue for regenerating optic axons in the adult CNS, unlike the PNS; and (3) robo2 is less important for pathfinding of optic axons during regeneration than during development.


Subject(s)
Axons/metabolism , Nerve Degeneration/metabolism , Nerve Regeneration/physiology , Optic Nerve/physiology , Receptors, Immunologic/metabolism , Zebrafish Proteins/metabolism , Animals , Axons/pathology , Immunohistochemistry , In Situ Hybridization , Nerve Degeneration/pathology , Optic Nerve/pathology , Receptors, Immunologic/genetics , Zebrafish/genetics , Zebrafish/metabolism , Zebrafish Proteins/genetics
4.
Mol Cell Neurosci ; 35(2): 194-207, 2007 Jun.
Article in English | MEDLINE | ID: mdl-17425960

ABSTRACT

Contactin1a (Cntn1a) is a zebrafish homolog of contactin1 (F3/F11/contactin) in mammals, an immunoglobulin superfamily recognition molecule of neurons and oligodendrocytes. We describe conspicuous Cntn1a mRNA expression in oligodendrocytes in the developing optic pathway of zebrafish. In adults, this expression is only retained in glial cells in the intraretinal optic fiber layer, which contains 'loose' myelin. After optic nerve lesion, oligodendrocytes re-express Cntn1a mRNA independently of the presence of regenerating axons and retinal ganglion cells upregulate Cntn1a expression to levels that are significantly higher than those during development. After spinal cord lesion, expression of Cntn1a mRNA is similarly increased in axotomized brainstem neurons and white matter glial cells in the spinal cord. In addition, reduced mRNA expression in the trigeminal/anterior lateral line ganglion in erbb3-deficient mutant larvae implies Cntn1a in Schwann cell differentiation. These complex regulation patterns suggest roles for Cntn1a in myelinating cells and neurons particularly in successful CNS regeneration.


Subject(s)
Cell Adhesion Molecules, Neuronal/metabolism , Cell Differentiation/physiology , Central Nervous System/pathology , Gene Expression Regulation, Developmental/physiology , Nerve Regeneration/physiology , Oligodendroglia/physiology , Animals , Animals, Genetically Modified , Animals, Newborn , Cell Adhesion Molecules, Neuronal/genetics , Central Nervous System/physiopathology , Contactin 1 , Contactins , Embryo, Nonmammalian , Eye Enucleation/methods , In Situ Hybridization/methods , Microscopy, Electron, Transmission/methods , Myelin P0 Protein/metabolism , Myelin-Associated Glycoprotein/metabolism , Neurons/physiology , Neurons/ultrastructure , Oligodendroglia/ultrastructure , Optic Nerve Injuries/pathology , Optic Nerve Injuries/physiopathology , RNA, Messenger/genetics , RNA, Messenger/metabolism , Receptor, ErbB-3/genetics , Spinal Cord Injuries/pathology , Spinal Cord Injuries/physiopathology , Zebrafish , Zebrafish Proteins
5.
Genetics ; 171(2): 597-614, 2005 Oct.
Article in English | MEDLINE | ID: mdl-15998720

ABSTRACT

Studies in the fly, Drosophila melanogaster, have revealed that several signaling pathways are important for the regulation of growth. Among these, the insulin receptor/phosphoinositide 3-kinase (PI3K) pathway is remarkable in that it affects growth and final size without disturbing pattern formation. We have used a small-wing phenotype, generated by misexpression of kinase-dead PI3K, to screen for novel mutations that specifically disrupt organ growth in vivo. We identified several complementation groups that dominantly enhance this small-wing phenotype. Meiotic recombination in conjunction with visible markers and single-nucleotide polymorphisms (SNPs) was used to map five enhancers to single genes. Two of these, nucampholin and prp8, encode pre-mRNA splicing factors. The three other enhancers encode factors required for mRNA translation: pixie encodes the Drosophila ortholog of yeast RLI1, and RpL5 and RpL38 encode proteins of the large ribosomal subunit. Interestingly, mutations in several other ribosomal protein-encoding genes also enhance the small-wing phenotype used in the original screen. Our work has therefore identified mutations in five previously uncharacterized Drosophila genes and provides in vivo evidence that normal organ growth requires optimal regulation of both pre-mRNA splicing and mRNA translation.


Subject(s)
Drosophila Proteins/genetics , Drosophila melanogaster/genetics , Protein Biosynthesis/genetics , RNA Splicing/genetics , Signal Transduction/genetics , Wings, Animal/growth & development , Amino Acid Sequence , Animals , Chromosome Mapping , Computational Biology , Crosses, Genetic , Drosophila melanogaster/growth & development , Gene Components , Genetic Complementation Test , Molecular Sequence Data , Mutagenesis , Mutation/genetics , Polymorphism, Single Nucleotide/genetics , Polymorphism, Single-Stranded Conformational
6.
Proc Natl Acad Sci U S A ; 101(39): 14276-81, 2004 Sep 28.
Article in English | MEDLINE | ID: mdl-15375215

ABSTRACT

The mushroom bodies are bilaterally arranged structures in the protocerebrum of Drosophila and most other insect species. Mutants with altered mushroom body structure have been instrumental not only in establishing their role in distinct behavioral functions but also in identifying the molecular pathways that control mushroom body development. The mushroom body miniature(1) (mbm(1)) mutation results in grossly reduced mushroom bodies and odor learning deficits in females. With a survey of genomic rescue constructs, we have pinpointed mbm(1) to a single transcription unit and identified a single nucleotide exchange in the 5' untranslated region of the corresponding transcript resulting in a reduced expression of the protein. The most obvious feature of the Mbm protein is a pair of C(2)HC zinc fingers, implicating a function of the protein in binding nucleic acids. Immunohistochemical analysis shows that expression of the Mbm protein is not restricted to the mushroom bodies. BrdUrd labeling experiments indicate a function of Mbm in neuronal precursor cell proliferation.


Subject(s)
Brain/embryology , Drosophila/embryology , Mushroom Bodies/physiology , Zinc Fingers/physiology , 5' Untranslated Regions , Amino Acid Sequence , Animals , Animals, Genetically Modified , Axons/physiology , Axons/ultrastructure , Brain/metabolism , Dendrites/physiology , Dendrites/ultrastructure , Drosophila/anatomy & histology , Drosophila/cytology , Drosophila/genetics , Drosophila Proteins/chemistry , Drosophila Proteins/physiology , Female , Gene Transfer Techniques , Immunohistochemistry , Larva/growth & development , Larva/ultrastructure , Mushroom Bodies/chemistry , Mushroom Bodies/cytology , Mutation , Phenotype , Recombinant Proteins/chemistry , Recombinant Proteins/genetics , Recombinant Proteins/metabolism , Recombinant Proteins/ultrastructure , Sequence Analysis, DNA , Transcription, Genetic
SELECTION OF CITATIONS
SEARCH DETAIL
...